Mid-sized life sciences companies are agile, have ambitious growth plans and seek innovation-driven differentiation to create value. Agilisium’s values match their expectations and they are one of their proud partners. To this end, Everest Group evaluated Agilisium’s capabilities across the entire life sciences value chain – from discovery to clinical trials and manufacturing to sales and marketing – as well as customer case studies and references.
“Being recognized as a market leader by an independent research firm, Everest Group, is a significant testament to our commitment to delivering superior digital solutions that address the most pressing needs of the life sciences industry. It is also an affirmation of Agilisium’s expertise in leveraging our digital services for the life sciences industry,” said Raj Babu, Founder and CEO of Agilisium. He added, “To specifically address the unique needs of mid-sized enterprises, Agilisium, backed by data from across LS capabilities, has created a collaborative ecosystem that brings together leading life sciences-centric partners, technology companies, academia and research institutions. The company has also invested significantly in Agilisium Labs, a dedicated innovation sandbox focused on developing advanced analytics and GenAI solutions across the life sciences value chain.”
“Mid-market life sciences companies face unique challenges that differentiate them from their larger competitors. To remain competitive, they must meet specific procurement requirements, such as customer intimacy, agility, and cost-effective innovation. Vendors are recognizing these specific requirements and adapting their strategies to offer personalized support and innovative solutions to capitalize on the growing demand from mid-market companies. Agilisium’s investment in building domain-specific IP and innovation labs, complemented by its commitment to proactively adding value to customer relationships, has helped the company achieve a leadership position in Everest Group’s 2024 PEAK Matrix® Assessment for Digital Life Sciences Services for Mid-Market Companies,” said Durga Ambati, Practice Director at Everest Group.
Click here to download the full report.
Agilisium’s clients include seven of the top 10 mid-sized life sciences companies. The company has brought on board experienced technology and domain experts and recruited senior talent from some of the leading life sciences companies such as Novartis, Amgen, Bayer, UCB and Sanofi to develop next-generation solutions that address the structural changes in the industry.
About Agilisium
Agilisium is a leading life sciences partner for digital innovation, delivering cutting-edge solutions that drive impactful change by combining our strong domain expertise with data, cloud, GenAI and advanced analytics. Agilisium partners with leading pharma and biotech companies to deliver data-driven insights and innovative solutions across the entire value chain to accelerate drug discovery, optimize patient care, achieve commercial success, streamline product delivery and foster collaboration. For more information, visit www.Agilisium.com
Don’t miss any more stories from Agilisium Consulting.
